Chengdu Easton Biopharmaceuticals Co., Ltd. (SHA:688513)
China · Delayed Price · Currency is CNY 64.39
-2.12 (-3.19%)
Feb 13, 2026, 3:00 PM CST
SHA:688513 Market Cap
SHA:688513 has a market cap or net worth of 11.23 billion as of February 13, 2026. Its market cap has increased by 110.48% in one year.
Market Cap
11.23B
Enterprise Value
9.79B
Revenue
1.33B
Ranking
n/a
PE Ratio
46.95
Stock Price
64.39
Market Cap Chart
Since September 2, 2020, SHA:688513's market cap has increased from 8.97B to 11.23B, an increase of 25.11%. That is a compound annual growth rate of 4.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 11.23B | 4.61% |
| Dec 31, 2025 | 10.73B | 104.34% |
| Dec 31, 2024 | 5.25B | -31.43% |
| Dec 29, 2023 | 7.66B | 4.83% |
| Dec 30, 2022 | 7.31B | 31.12% |
| Dec 31, 2021 | 5.57B | -2.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| InventisBio | 12.90B |
| Staidson (Beijing) BioPharmaceuticals | 12.90B |
| Hualan Biological Vaccine | 12.53B |
| Beijing Hotgen Biotech | 12.28B |
| Star Lake Bioscience Co., Inc.Zhaoqing Guangdong | 12.15B |
| HitGen | 11.92B |
| Vcanbio Cell & Gene Engineering Corp., | 11.60B |
| China Resources Boya Bio-pharmaceutical Group Co.,Ltd | 11.25B |